Yang Ying, Guo Tonglei, Fu Jinrong, Zhao Jun, Wang Yuanyuan, He Yuan, Peng Zuoqi, Zhang Ya, Zhang Hongguang, Zhang Yue, Wang Qiaomei, Shen Haiping, Zhang Yiping, Yan Donghai, Ma Xu, Guan Haixia
National Research Institute for Family Planning, National Human Genetic Resource Center, Beijing, China.
Graduate School of Peking Union Medical College, Dongdan Santiao, Beijing, China.
JAMA Netw Open. 2022 Aug 1;5(8):e2228892. doi: 10.1001/jamanetworkopen.2022.28892.
Abundant evidence suggests thyroid dysfunction is associated with adverse pregnancy outcomes. However, associations of preconception thyrotropin levels outside of reference range with reproductive health outcomes are not well characterized.
To evaluate the associations of preconception thyrotropin levels with time to pregnancy (TTP) and risk of spontaneous abortion (SA).
DESIGN, SETTING, AND PARTICIPANTS: This population-based cohort study used data from the Chinese National Free Prepregnancy Checkups Project. Female participants aged 20 to 49 years who were trying to conceive were enrolled between January 1, 2013, and December 31, 2016, for the analysis of TTP or SA. Data were analyzed between August 1, 2020, and July 5, 2021.
Levels of thyrotropin within 1 year prior to pregnancy.
The main outcomes were TTP, assessed using hazard ratios (HRs), and SA, assessed using odds ratios (ORs), according to preconception thyrotropin levels. Thyrotropin dose-response associations were assessed using restricted cubic spline regression.
Among 11 194 002 female participants (mean [SD] age, 27.56 [5.10] years) in the TTP cohort, 4 739 421 (42.34%) participants became pregnant within 1 year. Both low and high preconception thyrotropin levels were associated with delayed TTP compared with thyrotropin levels of 0.37 to 2.49 mIU/L (thyrotropin <0.10 mIU/L: HR, 0.90; 95% CI, 0.89-0.92; thyrotropin 4.88-9.99 mIU/L: HR, 0.86; 95% CI, 0.86-0.87; thyrotropin ≥10.00 mIU/L: HR, 0.78; 95% CI, 0.77-0.79). In the SA analysis cohort including 4 678 679 pregnancies, 108 064 SA events (2.31%) were documented. High thyrotropin groups showed an increased risk of SA compared with the group with thyrotropin levels of 0.37 to 2.49 mIU/L (thyrotropin 4.88-9.99 mIU/L: OR, 1.33; 95% CI, 1.28-1.38; thyrotropin ≥10.00 mIU/L: OR, 1.25; 95% CI, 1.14-1.36). Preconception thyrotropin levels showed an inverted J-shaped dose-response association with TTP (χ2 = 311.29; nonlinear P < .001) and a J-shaped dose-response association with SA (χ2 = 58.29; nonlinear P < .001).
In this cohort study, preconception thyrotropin levels outside of reference range were associated with increased risk of reduced fecundity and SA. These findings may provide insights for the implementation of preconception thyroid function screening and the design of future levothyroxine supplementation trials.
大量证据表明甲状腺功能障碍与不良妊娠结局相关。然而,孕前促甲状腺激素水平超出参考范围与生殖健康结局之间的关联尚未得到充分描述。
评估孕前促甲状腺激素水平与怀孕时间(TTP)及自然流产(SA)风险之间的关联。
设计、设置和参与者:这项基于人群的队列研究使用了中国国家免费孕前检查项目的数据。年龄在20至49岁之间、正在尝试怀孕的女性参与者于2013年1月1日至2016年12月31日被纳入研究,以分析TTP或SA。数据于2020年8月1日至2021年7月5日进行分析。
怀孕前1年内的促甲状腺激素水平。
主要结局为TTP,根据孕前促甲状腺激素水平,使用风险比(HR)进行评估;SA则使用比值比(OR)进行评估。促甲状腺激素的剂量反应关联使用受限立方样条回归进行评估。
在TTP队列的11194002名女性参与者(平均[标准差]年龄为27.56[5.10]岁)中,4739421名(42.34%)参与者在1年内怀孕。与促甲状腺激素水平为0.37至2.49 mIU/L相比,孕前促甲状腺激素水平过低和过高均与TTP延迟相关(促甲状腺激素<0.10 mIU/L:HR,0.90;95%置信区间,0.89 - 0.92;促甲状腺激素4.88 - 9.99 mIU/L:HR,0.86;95%置信区间,0.86 - 0.87;促甲状腺激素≥10.00 mIU/L:HR,0.78;95%置信区间,0.77 - 0.79)。在包括4678679次妊娠的SA分析队列中,记录了108064次SA事件(2.31%)。与促甲状腺激素水平为0.37至2.49 mIU/L的组相比,促甲状腺激素水平高的组SA风险增加(促甲状腺激素4.88 - 9.99 mIU/L:OR,1.33;95%置信区间,1.28 - 1.38;促甲状腺激素≥10.00 mIU/L:OR,1.25;95%置信区间,1.14 - 1.36)。孕前促甲状腺激素水平与TTP呈倒J形剂量反应关联(χ2 = 311.29;非线性P <.),与SA呈J形剂量反应关联(χ2 = 58.29;非线性P <.)。
在这项队列研究中,孕前促甲状腺激素水平超出参考范围与生育力降低和SA风险增加相关。这些发现可能为孕前甲状腺功能筛查的实施以及未来左甲状腺素补充试验的设计提供见解。